Pharmagreen Biotech Inc. Stock OTC Markets
Equities
PHBI
US00922N1046
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0289 USD | -.--% | -4.87% | +172.64% |
Financials (USD)
Sales 2022 | - | Sales 2023 | 0 | Capitalization | 401K |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | - |
Net Debt 2022 | 331K | Net Debt 2023 | 372K | EV / Sales 2023 | 257,842,228 x |
P/E ratio 2022 |
-4.61
x | P/E ratio 2023 |
-0.57
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.23% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Wojcik
CEO | Chief Executive Officer | 53 | 13-12-08 |
Terry Kwan
DFI | Director of Finance/CFO | 77 | 15-07-21 |
Ethan Styles
CTO | Chief Tech/Sci/R&D Officer | - | 22-09-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Wojcik
CEO | Chief Executive Officer | 53 | 13-12-08 |
Terry Kwan
DFI | Director of Finance/CFO | 77 | 15-07-21 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- PHBI Stock
- PHBI Stock